https://scholars.lib.ntu.edu.tw/handle/123456789/592743
標題: | Is the newest angiotensin-receptor blocker azilsartan medoxomil more efficacious in lowering blood pressure than the older ones? A systematic review and network meta-analysis | 作者: | Wang, Ji-Guang Zhang, Miao Feng, Ying-Qing Ma, Chang-Sheng TZUNG-DAU WANG Zhu, Zhi-Ming Kario, Kazuomi |
關鍵字: | ambulatory; angiotensin-receptor blocker; blood pressure; efficacy; network meta-analysis; systematic review | 公開日期: | 20-五月-2021 | 出版社: | WILEY | 卷: | 23 | 期: | 5 | 起(迄)頁: | 901 | 來源出版物: | Journal of clinical hypertension (Greenwich, Conn.) | 摘要: | Angiotensin-receptor blockers are often considered insufficiently efficacious in reducing blood pressure. However, newer angiotensin-receptor blockers may be more effective than the older ones. A network meta-analysis was performed to compare the efficacy of various angiotensin-receptor blockers in reducing office and ambulatory blood pressure in hypertensive patients. Relevant literature was searched from English and Chinese databases for randomized controlled trials involving angiotensin-receptor blockers in hypertension. Efficacy variables included systolic and diastolic blood pressure either in the office or on ambulatory blood pressure monitoring. Absolute blood pressure reductions at 6-12 weeks of treatment and their credible intervals were reported. A total of 34 publications provided adequate data for analysis (n = 14 859). In 28 studies on office systolic blood pressure (n = 12 731), against the common comparator valsartan 80 mg, the differences in systolic blood pressure were in favor of azilsartan medoxomil (20-80 mg), irbesartan (300 mg), olmesartan (20-40 mg), telmisartan (80 mg), and valsartan (160-320 mg), but not candesartan (8-16 mg), losartan (50-100 mg), irbesartan (150 mg), olmesartan (10 mg), and telmisartan (40 mg). The ranking plot shows that azilsartan medoxomil 80 mg had a possibility of 99% being the best in the class. Similar results were observed for office diastolic blood pressure and from 13 studies for 24-hour ambulatory systolic and diastolic blood pressure. In conclusion, angiotensin-receptor blockers had different blood pressure lowering efficacy. The newest angiotensin-receptor blocker azilsartan medoxomil at the dose of 80 mg seemed to be most efficacious in reducing both systolic and diastolic blood pressure in the office and on ambulatory measurement. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/592743 | ISSN: | 1524-6175 | DOI: | 10.1111/jch.14227 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。